NM_001159702.3:c.-26-9547G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001159702.3(FHL1):​c.-26-9547G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,163,238 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 66 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., 18 hem., cov: 23)
Exomes 𝑓: 0.00016 ( 0 hom. 48 hem. )

Consequence

FHL1
NM_001159702.3 intron

Scores

1
12

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.10

Publications

3 publications found
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
FHL1 Gene-Disease associations (from GenCC):
  • X-linked myopathy with postural muscle atrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • myopathy, reducing body, X-linked, early-onset, severe
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • reducing body myopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked scapuloperoneal muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008448601).
BP6
Variant X-136196860-G-A is Benign according to our data. Variant chrX-136196860-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 993975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00035 (39/111409) while in subpopulation AMR AF = 0.00171 (18/10496). AF 95% confidence interval is 0.00111. There are 0 homozygotes in GnomAd4. There are 18 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 18 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHL1NM_001159702.3 linkc.-26-9547G>A intron_variant Intron 2 of 7 ENST00000394155.8 NP_001153174.1 Q13642-2
FHL1NM_001159699.2 linkc.-253G>A upstream_gene_variant ENST00000370683.6 NP_001153171.1 Q13642-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHL1ENST00000394155.8 linkc.-26-9547G>A intron_variant Intron 2 of 7 5 NM_001159702.3 ENSP00000377710.2 Q13642-2
FHL1ENST00000370683.6 linkc.-253G>A upstream_gene_variant 1 NM_001159699.2 ENSP00000359717.1 Q13642-5

Frequencies

GnomAD3 genomes
AF:
0.000350
AC:
39
AN:
111355
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000686
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00172
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000990
AC:
112
AN:
113170
AF XY:
0.000693
show subpopulations
Gnomad AFR exome
AF:
0.000469
Gnomad AMR exome
AF:
0.00561
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000162
AC:
170
AN:
1051829
Hom.:
0
Cov.:
29
AF XY:
0.000140
AC XY:
48
AN XY:
342801
show subpopulations
African (AFR)
AF:
0.000603
AC:
15
AN:
24867
American (AMR)
AF:
0.00463
AC:
129
AN:
27887
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18622
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27127
South Asian (SAS)
AF:
0.0000201
AC:
1
AN:
49749
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3880
European-Non Finnish (NFE)
AF:
0.0000269
AC:
22
AN:
817819
Other (OTH)
AF:
0.0000677
AC:
3
AN:
44290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000350
AC:
39
AN:
111409
Hom.:
0
Cov.:
23
AF XY:
0.000535
AC XY:
18
AN XY:
33633
show subpopulations
African (AFR)
AF:
0.000684
AC:
21
AN:
30686
American (AMR)
AF:
0.00171
AC:
18
AN:
10496
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3544
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2581
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5966
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53079
Other (OTH)
AF:
0.00
AC:
0
AN:
1513
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.000774
ExAC
AF:
0.0000655
AC:
3

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 27, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FHL1-related disorder Benign:1
Jan 02, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.87
CADD
Benign
9.8
DANN
Benign
0.77
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.30
T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.0084
T
MetaSVM
Benign
-1.1
T
PhyloP100
1.1
PROVEAN
Benign
0.070
N
REVEL
Benign
0.080
Sift
Benign
0.54
T
Sift4G
Benign
0.63
T
Vest4
0.12
MVP
0.43
ClinPred
0.0024
T
GERP RS
-4.1
PromoterAI
0.032
Neutral
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs192893870; hg19: chrX-135279019; COSMIC: COSV61782755; COSMIC: COSV61782755; API